TransAct Technologies Inc, a supplier of slot machine printers, casino-player management software and food-safety management technology, reported fourth-quarter net sales of nearly US$11.5 million, up 11.9 percent from a year earlier.
The company posted a net loss of US$1.1 million for the three months to December 31, an improvement on the just below US$8.0-million loss in the prior-year period, according to a Tuesday press release.
The firm’s operating expenses for the October to December period rose 18.5 percent year-on-year, to US$6.6 million.
The increase in sales for the reporting period was a “result of stronger sales in both our casino and gaming, and food service technology (FST) markets,” TransAct stated.
Fourth-quarter sales in the casino and gaming segment rose 13.1 percent year-on-year, to nearly US$5.4 million.
Sales in the group’s FST segment stood at US$4.8 million, up 11.8 percent from a year ago.
TransAct reported negative adjusted earnings before interest, taxation, depreciation, and amortisation (EBITDA) of US$499,000 in the three months to December 31, compared with a negative figure of US$705,000 in the prior-year period.
John Dillon, TransAct’s chief executive, was quoted as saying in Tuesday’s announcement that the company had “delivered a strong fourth quarter and full year” results.
“These results reflect meaningful progress in our go-to-market execution and growing customer adoption of our FST solutions,” Mr Dillon stated.
“Our casino and gaming market also performed well and continues to provide steady cash flow” to fund the firm’s FST investments, he noted.
“We remain committed to fiscal discipline as we pursue this software-driven transformation to create long-term value for stockholders,” Mr Dillon added.
For full-year 2025, TransAct reported a net loss of just above US$1.2 million, on net sales that rose 18.7 percent year-on-year, to about US$51.5 million. Adjusted EBITDA stood at nearly US$1.2 million last year, compared to a negative figure of US$1.5 million in full-year 2024.
In Tuesday’s filing, TransAct said it expects to record total net sales of between US$55 million and US$57 million in full-year 2026. The firm forecast total adjusted EBITDA to be between US$800,000 and US$1.5 million.
In January this year, TransAct announced the appointment of Dana Loof as chief marketing officer, to oversee the group’s “global marketing strategy, unifying brand and product positioning, and driving demand and customer loyalty across the company’s core markets”.
